Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $145.00

Addus HomeCare (NASDAQ:ADUS) had its target price increased by Stephens from $143.00 to $145.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other equities analysts also recently commented on ADUS. Royal Bank of Canada lowered their target price on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating on the stock in a report on Wednesday. TD Cowen boosted their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Oppenheimer raised their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Macquarie reissued an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $127.58 on Wednesday. The company has a fifty day moving average of $129.60 and a 200 day moving average of $121.40. Addus HomeCare has a fifty-two week low of $81.51 and a fifty-two week high of $136.12. The company has a market capitalization of $2.31 billion, a P/E ratio of 29.19, a P/E/G ratio of 2.30 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same quarter last year, the company earned $1.03 EPS. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. Analysts forecast that Addus HomeCare will post 4.57 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now owns 3,866 shares in the company, valued at approximately $502,695.98. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now directly owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 over the last ninety days. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Texas Permanent School Fund Corp boosted its position in shares of Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after buying an additional 82 shares during the period. Arizona State Retirement System boosted its holdings in Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after acquiring an additional 87 shares during the period. UMB Bank n.a. grew its position in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the last quarter. Inspire Investing LLC grew its position in Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after acquiring an additional 100 shares during the last quarter. Finally, New York State Teachers Retirement System increased its stake in Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after purchasing an additional 100 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.